Welcome to the Health Marketing Collective, where strong leadership meets marketing excellence.
On today’s episode, we’re thrilled to welcome Kelly Franchetti, CEO of The Patient View, as she joins host Sara Payne for a candid discussion on what it truly means to put patients at the heart of health marketing. As an insights leader, nurse, and rare disease mom, Kelly fuses her unique personal and professional experiences to advocate for authentic patient engagement, offering actionable strategies for brands to move beyond lip service and embrace genuine patient-centricity.
Kelly brings a compelling perspective on the patient journey, informed by her own family’s experiences navigating rare diseases and clinical trials. She shares how her advocacy work led her to challenge the healthcare and pharma status quo, calling for substantive involvement of patients in every aspect of study design, marketing, and support program development.
Throughout the conversation, Sara and Kelly explore why “patient-centric” risks becoming just another buzzword, how to avoid costly missteps by listening to patient insights, and the organizational challenges that often stall efforts to turn data into change. They discuss real-life examples of brands pivoting strategies in response to patient feedback, and highlight the importance of enterprise-wide buy-in, frequent iteration, and empathy as foundational principles in modern health marketing.
Key Takeaways:
- Patient-Centricity Must Be Actionable, Not Just Aspirational:
- Kelly underscores that real patient-centricity requires actively seeking out patient perspectives through research and acting on what is learned. It’s not about relying solely on AI or superficial data; it’s about integrating genuine patient voices, frequently revisiting those insights, and ensuring they shape every aspect of marketing and brand strategy.
- Enterprise Buy-In Drives Change, While Siloes Stall Progress:
- One of the main reasons patient insights aren’t implemented is the lack of enterprise-level buy-in. Kelly points out that meaningful change rarely happens in fragmented organizations. Successful brands foster cross-functional alignment and maintain internal champions who advocate for patients throughout all stages of research, development, and commercialization.
- Early and Iterative Engagement Avoids Costly Missteps:
- Kelly shares powerful examples of campaigns and trial materials that dramatically changed direction thanks to patient feedback. For instance, using “the wrong shade of pink” for triple negative breast cancer materials nearly became an expensive mistake. Bringing patient input in early—and returning for further feedback during iteration—saves resources and enhances resonance.
- Empathy and Authenticity Build Trust:
- Marketers often underestimate how small gestures—like mentioning that support materials were created with real patients and caregivers—can foster trust. Empathy is the foundation of truly patient-centric marketing. It’s not enough to assume clinical expertise translates into understanding; language and context must be shaped by authentic patient experience.
- Patient Insights Can Be Quick, Cost-Effective, and Highly Influential:
- Kelly dispels myths that rigorous patient research is always expensive or slow. Reviewing existing data, leveraging small rapid studies, and continually refreshing patient advisory boards are accessible ways to keep messaging and services aligned with evolving patient needs. The key is to act, even if incrementally, and recognize that integrating the patient perspective is a journey—not a one-time project.
Don’t forget to subscribe wherever you get your podcasts. Thank you for tuning in to the Health Marketing Collective, where strong leadership meets marketing excellence. The future of healthcare depends on it.
